News

Filter

Current filters:

GenericsProsonix

1 to 9 of 97542 results

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

iCura Vision licenses macular degeneration portfolio from Columbia Technology Ventures

28-01-2015

Ophthalmic specialist iCura Vision has licensed the intellectual property portfolio and associated research…

iCura VisionLicensingOphthalmicsPharmaceuticalUSA

Amgen’s 4th-qtr 2014 earnings and sales beat expectations

Amgen’s 4th-qtr 2014 earnings and sales beat expectations

28-01-2015

US biotech major Amgen reported financial results after markets closed yesterday, revealing that fourth-quarter…

AmgenBiotechnologyFinancialUSA

First UK NICE highly specialized technologies guidance recommends Soliris

First UK NICE highly specialized technologies guidance recommends Soliris

28-01-2015

England’s health costs watchdog the National Institute for Health and care Excellence has today issued…

Alexion PharmaceuticalsBiotechnologyHematologyPricingRare diseasesRegulationSolarisUK

Fourth quarter Bristol-Myers Squibb results disappoint

Fourth quarter Bristol-Myers Squibb results disappoint

27-01-2015

Although the fourth quarter financial results from US drug major Bristol-Myers Squibb beat analyst estimates,…

Bristol-Myers SquibbFinancialPharmaceuticalUnited StatesUSA

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

27-01-2015

US pharma giant Pfizer today reported fourth-quarter 2014 earnings of $1.23 billion, and net earnings…

Corporate crimeDow Jones Industrial AverageFinancialPfizerPharmaceutical

Shire receives fast-track designation from FDA for SHP609 in Hunter syndrome

Shire receives fast-track designation from FDA for SHP609 in Hunter syndrome

27-01-2015

Ireland-headquartered drugmaker Shire has received fast-track designation from the US Food and Drug Administration…

NeurologicalPharmaceuticalRegulationShireSHP609

US FDA approves Symplmed and Servier’s Prestalia

US FDA approves Symplmed and Servier’s Prestalia

27-01-2015

Privately-held US drugmaker Symplmed Pharmaceuticals says that the US Food and Drug Administration has…

Cardio-vascularPharmaceuticalPrestaliaRegulationServierSymplmedUSA

1 to 9 of 97542 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top